Skip to main content
PMC home page
The British Journal of General Practice logoLink to The British Journal of General Practice
. 1996 Feb;46(403):77–79.

Prevalence, aetiology and management of heart failure in general practice.

F S Mair 1, T S Crowley 1, P E Bundred 1
PMCID: PMC1239534  PMID: 8855012

Abstract

BACKGROUND: There is a high level of morbidity and mortality among patients with heart failure. Management of the condition has changed substantially in recent years. However, there is little information on the management of heart failure in general practice. AIM: A study was carried out in 1994 to assess the prevalence, aetiology and management of heart failure in a general practice setting. METHOD: A retrospective review was undertaken of the manual and computerized medical records of patients in two group practices in Liverpool (combined patient population of 17 400). RESULTS: A total of 266 patients with heart failure were identified (a prevalence of 15 per 1000). The two practices had 2747 patients who were aged 65 years and over and 221 of these had heart failure (prevalence of 80 per 1000). The principal aetiological factor considered responsible for heart failure was: coronary heart disease in 45% of patients, hypertension 18%, valve disease 9%, cor pulmonale 7%, cardiomyopathy 2% and a metabolic problem 2% (aetiology unknown in 17% of cases). Urea and electrolytes had been checked in the last year in 59% of patients. Chest x-ray and electrocardiography had been performed in 89% and 80% of patients, respectively, and echocardiography in 30%. Angiotensin converting enzyme (ACE) inhibitors were being prescribed to 33% of patients. CONCLUSION: The study found a high prevalence of heart failure among patients aged 65 years and over. Coronary heart disease was considered to be the main aetiological factor. Patients were being investigated mainly by means of chest x-ray and electrocardiography. Most patients with heart failure were not receiving treatment with ACE inhibitors. Evaluation of heart failure by clinical criteria alone is now deemed insufficient. Echocardiography should be used routinely to assess cardiac dysfunction. Patients with confirmed left ventricular dysfunction will benefit from treatment with ACE inhibitors unless contraindications exist. The study suggests that there is a need to explore ways of optimizing the management of patients with heart failure.

Full text

PDF
77

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  2. Dargie H. J., McMurray J. J. Diagnosis and management of heart failure. BMJ. 1994 Jan 29;308(6924):321–328. doi: 10.1136/bmj.308.6924.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DiBianco R. A large-scale trial of captopril for mild to moderate heart failure in the primary care setting. Clin Cardiol. 1991 Aug;14(8):676–682. doi: 10.1002/clc.4960140810. [DOI] [PubMed] [Google Scholar]
  4. Franciosa J. A. Epidemiologic patterns, clinical evaluation, and long-term prognosis in chronic congestive heart failure. Am J Med. 1986 Feb 28;80(2B):14–21. doi: 10.1016/0002-9343(86)90139-7. [DOI] [PubMed] [Google Scholar]
  5. Grady K. L. Quality of life in patients with chronic heart failure. Crit Care Nurs Clin North Am. 1993 Dec;5(4):661–670. [PubMed] [Google Scholar]
  6. Kannel W. B. Epidemiological aspects of heart failure. Cardiol Clin. 1989 Feb;7(1):1–9. [PubMed] [Google Scholar]
  7. McMurray J., McDonagh T., Morrison C. E., Dargie H. J. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J. 1993 Sep;14(9):1158–1162. doi: 10.1093/eurheartj/14.9.1158. [DOI] [PubMed] [Google Scholar]
  8. Pacher R., Globits S., Bergler-Klein J., Teufelsbauer H., Wutte M., Baumgartner W., Ogris E., Glogar D. Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages. Eur Heart J. 1993 Feb;14(2):273–278. doi: 10.1093/eurheartj/14.2.273. [DOI] [PubMed] [Google Scholar]
  9. Parameshwar J., Shackell M. M., Richardson A., Poole-Wilson P. A., Sutton G. C. Prevalence of heart failure in three general practices in north west London. Br J Gen Pract. 1992 Jul;42(360):287–289. [PMC free article] [PubMed] [Google Scholar]
  10. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES